APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Animal Microbiome

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Animal Microbiome Market Analysis and Forecast 2026-2032

Report ID 17396412022 January 2026203 pages

Choose your research edition.

Industry ResearchAnimal Microbiome Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Microbiome Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Animal Microbiome Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Microbiome Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Microbiome Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Animal Microbiome market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Animal Microbiome is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Animal Microbiome is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Animal Microbiome is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Animal Microbiome is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Animal Microbiome include Adisseo, Animab, AnimalBiome, Anizome, BaseClear, CanBiocin, Chr. Hansen Holding, DNA Genotek and Hill's Pet Nutrition, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Animal Microbiome, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Animal Microbiome, also provides the revenue of main regions and countries. Of the upcoming market potential for Animal Microbiome, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Animal Microbiome revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Animal Microbiome market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Animal Microbiome revenue, projected growth trends, production technology, application and end-user industry.

Animal Microbiome Segment by Company

Adisseo

Animab

AnimalBiome

Anizome

BaseClear

CanBiocin

Chr. Hansen Holding

DNA Genotek

Hill's Pet Nutrition

IFF

Lallemand

Lesaffre

MicroSintesis

MiDOG

Pando Nutrition

ProDigest

Tharos Ltd.

Animal Microbiome Segment by Type

Testing Service

Supplemental Product

Animal Microbiome Segment by Application

Skin Condition

Vomiting

Chronic Diarrhea

Constipation

Other

Animal Microbiome Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Microbiome market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Microbiome and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Microbiome.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Animal Microbiome in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Animal Microbiome company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Microbiome revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Animal Microbiome Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Testing Service Major Player Table 3. Supplemental Product Major Player Table 4. Global Animal Microbiome Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Skin Condition Major Player Table 6. Vomiting Major Player Table 7. Chronic Diarrhea Major Player Table 8. Constipation Major Player Table 9. Other Major Player Table 10. Animal Microbiome Industry Trends Table 11. Animal Microbiome Industry Drivers Table 12. Animal Microbiome Industry Opportunities and Challenges Table 13. Animal Microbiome Industry Restraints Table 14. Global Animal Microbiome Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Animal Microbiome Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Animal Microbiome Market Share by Region (2021-2026) Table 17. Global Animal Microbiome Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Animal Microbiome Market Share by Region (2027-2032) Table 19. Global Animal Microbiome Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Animal Microbiome Revenue Market Share by Players (2021-2026) Table 21. Global Animal Microbiome Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Animal Microbiome Key Players Headquarters & Area Served Table 23. Global Animal Microbiome Players, Product Type & Application Table 24. Global Animal Microbiome Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Animal Microbiome by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Animal Microbiome Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Animal Microbiome Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Animal Microbiome Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Animal Microbiome Revenue Market Share by Type (2021-2026) Table 31. Global Animal Microbiome Revenue Market Share by Type (2027-2032) Table 32. Global Animal Microbiome Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Animal Microbiome Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Animal Microbiome Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Animal Microbiome Revenue Market Share by Application (2021-2026) Table 36. Global Animal Microbiome Revenue Market Share by Application (2027-2032) Table 37. Adisseo Company Information Table 38. Adisseo Business Overview Table 39. Adisseo Animal Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Adisseo Animal Microbiome Product Portfolio Table 41. Adisseo Recent Development Table 42. Animab Company Information Table 43. Animab Business Overview Table 44. Animab Animal Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Animab Animal Microbiome Product Portfolio Table 46. Animab Recent Development Table 47. AnimalBiome Company Information Table 48. AnimalBiome Business Overview Table 49. AnimalBiome Animal Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. AnimalBiome Animal Microbiome Product Portfolio Table 51. AnimalBiome Recent Development Table 52. Anizome Company Information Table 53. Anizome Business Overview Table 54. Anizome Animal Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Anizome Animal Microbiome Product Portfolio Table 56. Anizome Recent Development Table 57. BaseClear Company Information Table 58. BaseClear Business Overview Table 59. BaseClear Animal Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. BaseClear Animal Microbiome Product Portfolio Table 61. BaseClear Recent Development Table 62. CanBiocin Company Information Table 63. CanBiocin Business Overview Table 64. CanBiocin Animal Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. CanBiocin Animal Microbiome Product Portfolio Table 66. CanBiocin Recent Development Table 67. Chr. Hansen Holding Company Information Table 68. Chr. Hansen Holding Business Overview Table 69. Chr. Hansen Holding Animal Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Chr. Hansen Holding Animal Microbiome Product Portfolio Table 71. Chr. Hansen Holding Recent Development Table 72. DNA Genotek Company Information Table 73. DNA Genotek Business Overview Table 74. DNA Genotek Animal Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. DNA Genotek Animal Microbiome Product Portfolio Table 76. DNA Genotek Recent Development Table 77. Hill's Pet Nutrition Company Information Table 78. Hill's Pet Nutrition Business Overview Table 79. Hill's Pet Nutrition Animal Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Hill's Pet Nutrition Animal Microbiome Product Portfolio Table 81. Hill's Pet Nutrition Recent Development Table 82. IFF Company Information Table 83. IFF Business Overview Table 84. IFF Animal Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. IFF Animal Microbiome Product Portfolio Table 86. IFF Recent Development Table 87. Lallemand Company Information Table 88. Lallemand Business Overview Table 89. Lallemand Animal Microbiome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Lallemand Animal Microbiome Product Portfolio Table 91. Lallemand Recent Development Table 92. Lesaffre Company Information Table 93. Lesaffre Business Overview Table 94. Lesaffre Animal Microbiome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Lesaffre Animal Microbiome Product Portfolio Table 96. Lesaffre Recent Development Table 97. MicroSintesis Company Information Table 98. MicroSintesis Business Overview Table 99. MicroSintesis Animal Microbiome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. MicroSintesis Animal Microbiome Product Portfolio Table 101. MicroSintesis Recent Development Table 102. MiDOG Company Information Table 103. MiDOG Business Overview Table 104. MiDOG Animal Microbiome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. MiDOG Animal Microbiome Product Portfolio Table 106. MiDOG Recent Development Table 107. Pando Nutrition Company Information Table 108. Pando Nutrition Business Overview Table 109. Pando Nutrition Animal Microbiome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pando Nutrition Animal Microbiome Product Portfolio Table 111. Pando Nutrition Recent Development Table 112. ProDigest Company Information Table 113. ProDigest Business Overview Table 114. ProDigest Animal Microbiome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. ProDigest Animal Microbiome Product Portfolio Table 116. ProDigest Recent Development Table 117. Tharos Ltd. Company Information Table 118. Tharos Ltd. Business Overview Table 119. Tharos Ltd. Animal Microbiome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Tharos Ltd. Animal Microbiome Product Portfolio Table 121. Tharos Ltd. Recent Development Table 122. North America Animal Microbiome Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Animal Microbiome Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Animal Microbiome Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Animal Microbiome Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Animal Microbiome Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Animal Microbiome Revenue by Country (2021-2026) & (US$ Million) Table 128. North America Animal Microbiome Revenue by Country (US$ Million) & (2027-2032) Table 129. Europe Animal Microbiome Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Animal Microbiome Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Animal Microbiome Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Animal Microbiome Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Animal Microbiome Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Animal Microbiome Revenue by Country (2021-2026) & (US$ Million) Table 135. Europe Animal Microbiome Revenue by Country (US$ Million) & (2027-2032) Table 136. China Animal Microbiome Revenue by Type (2021-2026) & (US$ Million) Table 137. China Animal Microbiome Revenue by Type (2027-2032) & (US$ Million) Table 138. China Animal Microbiome Revenue by Application (2021-2026) & (US$ Million) Table 139. China Animal Microbiome Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Animal Microbiome Revenue by Type (2021-2026) & (US$ Million) Table 141. Asia Animal Microbiome Revenue by Type (2027-2032) & (US$ Million) Table 142. Asia Animal Microbiome Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Animal Microbiome Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Animal Microbiome Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Animal Microbiome Revenue by Region (US$ Million) & (2021-2026) Table 146. Asia Animal Microbiome Revenue by Region (US$ Million) & (2027-2032) Table 147. SAMEA Animal Microbiome Revenue by Type (2021-2026) & (US$ Million) Table 148. SAMEA Animal Microbiome Revenue by Type (2027-2032) & (US$ Million) Table 149. SAMEA Animal Microbiome Revenue by Application (2021-2026) & (US$ Million) Table 150. SAMEA Animal Microbiome Revenue by Application (2027-2032) & (US$ Million) Table 151. SAMEA Animal Microbiome Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. SAMEA Animal Microbiome Revenue by Country (2021-2026) & (US$ Million) Table 153. SAMEA Animal Microbiome Revenue by Country (US$ Million) & (2027-2032) Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Animal Microbiome Image Figure 2. Global Animal Microbiome Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Microbiome Market Size Share 2021 VS 2025 VS 2032 Figure 4. Testing Service Image Figure 5. Supplemental Product Image Figure 6. Global Animal Microbiome Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Animal Microbiome Market Size Share 2021 VS 2025 VS 2032 Figure 8. Skin Condition Image Figure 9. Vomiting Image Figure 10. Chronic Diarrhea Image Figure 11. Constipation Image Figure 12. Other Image Figure 13. Global Animal Microbiome Market Size (US$ Million) & (2021-2032) Figure 14. Global Animal Microbiome Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Animal Microbiome Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Animal Microbiome Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Animal Microbiome Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Animal Microbiome Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Animal Microbiome Revenue Market Share by Type (2021-2032) Figure 21. Global Animal Microbiome Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Animal Microbiome Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Animal Microbiome Revenue Market Share by Application (2021-2032) Figure 24. North America Animal Microbiome Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Animal Microbiome Revenue Share by Type (2021-2032) Figure 26. North America Animal Microbiome Revenue Share by Application (2021-2032) Figure 27. North America Animal Microbiome Revenue Share by Country (2021-2032) Figure 28. United States Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Animal Microbiome Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Animal Microbiome Revenue Share by Type (2021-2032) Figure 33. Europe Animal Microbiome Revenue Share by Application (2021-2032) Figure 34. Europe Animal Microbiome Revenue Share by Country (2021-2032) Figure 35. Germany Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Animal Microbiome Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Animal Microbiome Revenue Share by Type (2021-2032) Figure 45. China Animal Microbiome Revenue Share by Application (2021-2032) Figure 46. Asia Animal Microbiome Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Animal Microbiome Revenue Share by Type (2021-2032) Figure 48. Asia Animal Microbiome Revenue Share by Application (2021-2032) Figure 49. Asia Animal Microbiome Revenue Share by Region (2021-2032) Figure 50. Japan Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Animal Microbiome Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Animal Microbiome Revenue Share by Type (2021-2032) Figure 58. SAMEA Animal Microbiome Revenue Share by Application (2021-2032) Figure 59. SAMEA Animal Microbiome Revenue Share by Country (2021-2032) Figure 60. Brazil Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Animal Microbiome Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Testing Service
  • Supplemental Product
Applications
  • Skin Condition
  • Vomiting
  • Chronic Diarrhea
  • Constipation
  • Other
Companies covered
  • Adisseo
  • Animab
  • AnimalBiome
  • Anizome
  • BaseClear
  • CanBiocin
  • Chr. Hansen Holding
  • DNA Genotek
  • Hill's Pet Nutrition
  • IFF
  • Lallemand
  • Lesaffre
  • MicroSintesis
  • MiDOG
  • Pando Nutrition
  • ProDigest
  • Tharos Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Animal Microbiome Market by Type
  3. 1.2.1 Global Animal Microbiome Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Testing Service
  5. 1.2.3 Supplemental Product
  6. 1.3 Animal Microbiome Market by Application
  7. 1.3.1 Global Animal Microbiome Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Skin Condition
  9. 1.3.3 Vomiting
  10. 1.3.4 Chronic Diarrhea
  11. 1.3.5 Constipation
  12. 1.3.6 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Animal Microbiome Market Dynamics
  1. 2.1 Animal Microbiome Industry Trends
  2. 2.2 Animal Microbiome Industry Drivers
  3. 2.3 Animal Microbiome Industry Opportunities and Challenges
  4. 2.4 Animal Microbiome Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Animal Microbiome Market Perspective (2021-2032)
  2. 3.2 Global Animal Microbiome Growth Trends by Region
  3. 3.2.1 Global Animal Microbiome Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Animal Microbiome Market Size by Region (2021-2026)
  5. 3.2.3 Global Animal Microbiome Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Animal Microbiome Revenue by Players
  2. 4.1.1 Global Animal Microbiome Revenue by Players (2021-2026)
  3. 4.1.2 Global Animal Microbiome Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Animal Microbiome Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Animal Microbiome Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Animal Microbiome Key Players Headquarters & Area Served
  7. 4.4 Global Animal Microbiome Players, Product Type & Application
  8. 4.5 Global Animal Microbiome Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Animal Microbiome Market CR5 and HHI
  11. 4.6.3 2025 Animal Microbiome Tier 1, Tier 2, and Tier 3
5 Animal Microbiome Market Size by Type
  1. 5.1 Global Animal Microbiome Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Animal Microbiome Revenue by Type (2021-2032)
  3. 5.3 Global Animal Microbiome Revenue Market Share by Type (2021-2032)
6 Animal Microbiome Market Size by Application
  1. 6.1 Global Animal Microbiome Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Animal Microbiome Revenue by Application (2021-2032)
  3. 6.3 Global Animal Microbiome Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Adisseo
  2. 7.1.1 Adisseo Company Information
  3. 7.1.2 Adisseo Business Overview
  4. 7.1.3 Adisseo Animal Microbiome Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Adisseo Animal Microbiome Product Portfolio
  6. 7.1.5 Adisseo Recent Developments
  7. 7.2 Animab
  8. 7.2.1 Animab Company Information
  9. 7.2.2 Animab Business Overview
  10. 7.2.3 Animab Animal Microbiome Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Animab Animal Microbiome Product Portfolio
  12. 7.2.5 Animab Recent Developments
  13. 7.3 AnimalBiome
  14. 7.3.1 AnimalBiome Company Information
  15. 7.3.2 AnimalBiome Business Overview
  16. 7.3.3 AnimalBiome Animal Microbiome Revenue and Gross Margin (2021-2026)
  17. 7.3.4 AnimalBiome Animal Microbiome Product Portfolio
  18. 7.3.5 AnimalBiome Recent Developments
  19. 7.4 Anizome
  20. 7.4.1 Anizome Company Information
  21. 7.4.2 Anizome Business Overview
  22. 7.4.3 Anizome Animal Microbiome Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Anizome Animal Microbiome Product Portfolio
  24. 7.4.5 Anizome Recent Developments
  25. 7.5 BaseClear
  26. 7.5.1 BaseClear Company Information
  27. 7.5.2 BaseClear Business Overview
  28. 7.5.3 BaseClear Animal Microbiome Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BaseClear Animal Microbiome Product Portfolio
  30. 7.5.5 BaseClear Recent Developments
  31. 7.6 CanBiocin
  32. 7.6.1 CanBiocin Company Information
  33. 7.6.2 CanBiocin Business Overview
  34. 7.6.3 CanBiocin Animal Microbiome Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CanBiocin Animal Microbiome Product Portfolio
  36. 7.6.5 CanBiocin Recent Developments
  37. 7.7 Chr. Hansen Holding
  38. 7.7.1 Chr. Hansen Holding Company Information
  39. 7.7.2 Chr. Hansen Holding Business Overview
  40. 7.7.3 Chr. Hansen Holding Animal Microbiome Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Chr. Hansen Holding Animal Microbiome Product Portfolio
  42. 7.7.5 Chr. Hansen Holding Recent Developments
  43. 7.8 DNA Genotek
  44. 7.8.1 DNA Genotek Company Information
  45. 7.8.2 DNA Genotek Business Overview
  46. 7.8.3 DNA Genotek Animal Microbiome Revenue and Gross Margin (2021-2026)
  47. 7.8.4 DNA Genotek Animal Microbiome Product Portfolio
  48. 7.8.5 DNA Genotek Recent Developments
  49. 7.9 Hill's Pet Nutrition
  50. 7.9.1 Hill's Pet Nutrition Company Information
  51. 7.9.2 Hill's Pet Nutrition Business Overview
  52. 7.9.3 Hill's Pet Nutrition Animal Microbiome Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Hill's Pet Nutrition Animal Microbiome Product Portfolio
  54. 7.9.5 Hill's Pet Nutrition Recent Developments
  55. 7.10 IFF
  56. 7.10.1 IFF Company Information
  57. 7.10.2 IFF Business Overview
  58. 7.10.3 IFF Animal Microbiome Revenue and Gross Margin (2021-2026)
  59. 7.10.4 IFF Animal Microbiome Product Portfolio
  60. 7.10.5 IFF Recent Developments
  61. 7.11 Lallemand
  62. 7.11.1 Lallemand Company Information
  63. 7.11.2 Lallemand Business Overview
  64. 7.11.3 Lallemand Animal Microbiome Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Lallemand Animal Microbiome Product Portfolio
  66. 7.11.5 Lallemand Recent Developments
  67. 7.12 Lesaffre
  68. 7.12.1 Lesaffre Company Information
  69. 7.12.2 Lesaffre Business Overview
  70. 7.12.3 Lesaffre Animal Microbiome Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Lesaffre Animal Microbiome Product Portfolio
  72. 7.12.5 Lesaffre Recent Developments
  73. 7.13 MicroSintesis
  74. 7.13.1 MicroSintesis Company Information
  75. 7.13.2 MicroSintesis Business Overview
  76. 7.13.3 MicroSintesis Animal Microbiome Revenue and Gross Margin (2021-2026)
  77. 7.13.4 MicroSintesis Animal Microbiome Product Portfolio
  78. 7.13.5 MicroSintesis Recent Developments
  79. 7.14 MiDOG
  80. 7.14.1 MiDOG Company Information
  81. 7.14.2 MiDOG Business Overview
  82. 7.14.3 MiDOG Animal Microbiome Revenue and Gross Margin (2021-2026)
  83. 7.14.4 MiDOG Animal Microbiome Product Portfolio
  84. 7.14.5 MiDOG Recent Developments
  85. 7.15 Pando Nutrition
  86. 7.15.1 Pando Nutrition Company Information
  87. 7.15.2 Pando Nutrition Business Overview
  88. 7.15.3 Pando Nutrition Animal Microbiome Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Pando Nutrition Animal Microbiome Product Portfolio
  90. 7.15.5 Pando Nutrition Recent Developments
  91. 7.16 ProDigest
  92. 7.16.1 ProDigest Company Information
  93. 7.16.2 ProDigest Business Overview
  94. 7.16.3 ProDigest Animal Microbiome Revenue and Gross Margin (2021-2026)
  95. 7.16.4 ProDigest Animal Microbiome Product Portfolio
  96. 7.16.5 ProDigest Recent Developments
  97. 7.17 Tharos Ltd.
  98. 7.17.1 Tharos Ltd. Company Information
  99. 7.17.2 Tharos Ltd. Business Overview
  100. 7.17.3 Tharos Ltd. Animal Microbiome Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Tharos Ltd. Animal Microbiome Product Portfolio
  102. 7.17.5 Tharos Ltd. Recent Developments
8 North America
  1. 8.1 North America Animal Microbiome Revenue (2021-2032)
  2. 8.2 North America Animal Microbiome Revenue by Type (2021-2032)
  3. 8.2.1 North America Animal Microbiome Revenue by Type (2021-2026)
  4. 8.2.2 North America Animal Microbiome Revenue by Type (2027-2032)
  5. 8.3 North America Animal Microbiome Revenue Share by Type (2021-2032)
  6. 8.4 North America Animal Microbiome Revenue by Application (2021-2032)
  7. 8.4.1 North America Animal Microbiome Revenue by Application (2021-2026)
  8. 8.4.2 North America Animal Microbiome Revenue by Application (2027-2032)
  9. 8.5 North America Animal Microbiome Revenue Share by Application (2021-2032)
  10. 8.6 North America Animal Microbiome Revenue by Country
  11. 8.6.1 North America Animal Microbiome Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Animal Microbiome Revenue by Country (2021-2026)
  13. 8.6.3 North America Animal Microbiome Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Animal Microbiome Revenue (2021-2032)
  2. 9.2 Europe Animal Microbiome Revenue by Type (2021-2032)
  3. 9.2.1 Europe Animal Microbiome Revenue by Type (2021-2026)
  4. 9.2.2 Europe Animal Microbiome Revenue by Type (2027-2032)
  5. 9.3 Europe Animal Microbiome Revenue Share by Type (2021-2032)
  6. 9.4 Europe Animal Microbiome Revenue by Application (2021-2032)
  7. 9.4.1 Europe Animal Microbiome Revenue by Application (2021-2026)
  8. 9.4.2 Europe Animal Microbiome Revenue by Application (2027-2032)
  9. 9.5 Europe Animal Microbiome Revenue Share by Application (2021-2032)
  10. 9.6 Europe Animal Microbiome Revenue by Country
  11. 9.6.1 Europe Animal Microbiome Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Animal Microbiome Revenue by Country (2021-2026)
  13. 9.6.3 Europe Animal Microbiome Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Animal Microbiome Revenue (2021-2032)
  2. 10.2 China Animal Microbiome Revenue by Type (2021-2032)
  3. 10.2.1 China Animal Microbiome Revenue by Type (2021-2026)
  4. 10.2.2 China Animal Microbiome Revenue by Type (2027-2032)
  5. 10.3 China Animal Microbiome Revenue Share by Type (2021-2032)
  6. 10.4 China Animal Microbiome Revenue by Application (2021-2032)
  7. 10.4.1 China Animal Microbiome Revenue by Application (2021-2026)
  8. 10.4.2 China Animal Microbiome Revenue by Application (2027-2032)
  9. 10.5 China Animal Microbiome Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Animal Microbiome Revenue (2021-2032)
  2. 11.2 Asia Animal Microbiome Revenue by Type (2021-2032)
  3. 11.2.1 Asia Animal Microbiome Revenue by Type (2021-2026)
  4. 11.2.2 Asia Animal Microbiome Revenue by Type (2027-2032)
  5. 11.3 Asia Animal Microbiome Revenue Share by Type (2021-2032)
  6. 11.4 Asia Animal Microbiome Revenue by Application (2021-2032)
  7. 11.4.1 Asia Animal Microbiome Revenue by Application (2021-2026)
  8. 11.4.2 Asia Animal Microbiome Revenue by Application (2027-2032)
  9. 11.5 Asia Animal Microbiome Revenue Share by Application (2021-2032)
  10. 11.6 Asia Animal Microbiome Revenue by Country
  11. 11.6.1 Asia Animal Microbiome Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Animal Microbiome Revenue by Country (2021-2026)
  13. 11.6.3 Asia Animal Microbiome Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Animal Microbiome Revenue (2021-2032)
  2. 12.2 SAMEA Animal Microbiome Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Animal Microbiome Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Animal Microbiome Revenue by Type (2027-2032)
  5. 12.3 SAMEA Animal Microbiome Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Animal Microbiome Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Animal Microbiome Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Animal Microbiome Revenue by Application (2027-2032)
  9. 12.5 SAMEA Animal Microbiome Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Animal Microbiome Revenue by Country
  11. 12.6.1 SAMEA Animal Microbiome Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Animal Microbiome Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Animal Microbiome Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst